These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19911067)

  • 1. Correlation of plasma MMP-1 and TIMP-1 levels and the colonic mucosa expressions in patients with ulcerative colitis.
    Wang YD; Tan XY; Zhang K
    Mediators Inflamm; 2009; 2009():275072. PubMed ID: 19911067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in ulcerative colitis.
    Wang YD; Yan PY
    World J Gastroenterol; 2006 Oct; 12(37):6050-3. PubMed ID: 17009408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 as biomarkers of ulcerative colitis activity.
    Wiercinska-Drapalo A; Jaroszewicz J; Flisiak R; Prokopowicz D
    World J Gastroenterol; 2003 Dec; 9(12):2843-5. PubMed ID: 14669348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn's Disease.
    Piechota-Polanczyk A; Włodarczyk M; Sobolewska-Włodarczyk A; Jonakowski M; Pilarczyk A; Stec-Michalska K; Wiśniewska-Jarosińska M; Fichna J
    Dig Dis Sci; 2017 Jun; 62(6):1511-1517. PubMed ID: 28391416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of matrix metalloproteinase-1 and tumor necrosis factor-alpha in ulcerative colitis.
    Wang YD; Mao JW
    World J Gastroenterol; 2007 Nov; 13(44):5926-32. PubMed ID: 17990358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease.
    McKaig BC; McWilliams D; Watson SA; Mahida YR
    Am J Pathol; 2003 Apr; 162(4):1355-60. PubMed ID: 12651627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of MMP-2, MMP-7, MMP-9, and TIMP-1 by Inflamed Mucosa in the Initial Diagnosis of Ulcerative Colitis as a Response Marker for Conventional Medical Treatment.
    Eiro N; Barreiro-Alonso E; Fraile M; González LO; Altadill A; Vizoso FJ
    Pathobiology; 2023; 90(2):81-93. PubMed ID: 35797965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of ilomastat on trinitrobenzenesulfonic acid-induced ulcerative colitis in rats.
    Wang YD; Wang W
    World J Gastroenterol; 2008 Oct; 14(37):5683-8. PubMed ID: 18837084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The behavior of matrix metalloproteinase-9 in lymphocytic colitis, collagenous colitis and ulcerative colitis.
    Lakatos G; Sipos F; Miheller P; Hritz I; Varga MZ; Juhász M; Molnár B; Tulassay Z; Herszényi L
    Pathol Oncol Res; 2012 Jan; 18(1):85-91. PubMed ID: 21678108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.
    Louis E; Ribbens C; Godon A; Franchimont D; De Groote D; Hardy N; Boniver J; Belaiche J; Malaise M
    Clin Exp Immunol; 2000 May; 120(2):241-6. PubMed ID: 10792371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease.
    von Lampe B; Barthel B; Coupland SE; Riecken EO; Rosewicz S
    Gut; 2000 Jul; 47(1):63-73. PubMed ID: 10861266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal MMP-9: a new noninvasive differential diagnostic and activity marker in ulcerative colitis.
    Annaházi A; Molnár T; Farkas K; Rosztóczy A; Izbéki F; Gecse K; Inczefi O; Nagy F; Földesi I; Szűcs M; Dabek M; Ferrier L; Theodorou V; Bueno L; Wittmann T; Róka R
    Inflamm Bowel Dis; 2013 Feb; 19(2):316-20. PubMed ID: 22550024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis.
    Zhang BB; Cai WM; Weng HL; Hu ZR; Lu J; Zheng M; Liu RH
    World J Gastroenterol; 2003 Nov; 9(11):2490-6. PubMed ID: 14606082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.
    Lorenzl S; Buerger K; Hampel H; Beal MF
    Int Psychogeriatr; 2008 Feb; 20(1):67-76. PubMed ID: 17697439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1.
    Flisiak I; Myśliwiec H; Chodynicka B
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):418-21. PubMed ID: 15987285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?
    Marín F; Roldán V; Climent V; Garcia A; Marco P; Lip GY
    Stroke; 2003 May; 34(5):1181-6. PubMed ID: 12663879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Useful as Markers in Diagnostic Management of Children with Newly Diagnosed Ulcerative Colitis?
    Czajkowska A; Guzinska-Ustymowicz K; Pryczynicz A; Lebensztejn D; Daniluk U
    J Clin Med; 2022 May; 11(9):. PubMed ID: 35566780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
    AbdElazeem MA; El-Sayed M
    Ann Diagn Pathol; 2015 Dec; 19(6):369-74. PubMed ID: 26420348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase, tissue inhibitor of metalloproteinase and transforming growth factor-beta 1 in frozen shoulder, and their changes as response to intensive stretching and supervised neglect exercise.
    Lubis AM; Lubis VK
    J Orthop Sci; 2013 Jul; 18(4):519-27. PubMed ID: 23604641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of serum matrix metalloproteinases and their tissue inhibitor levels with scleroderma disease severity.
    Toubi E; Kessel A; Grushko G; Sabo E; Rozenbaum M; Rosner I
    Clin Exp Rheumatol; 2002; 20(2):221-4. PubMed ID: 12051403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.